Skip to content

Helen Of Troy HELE Proceeds from share issuances under share-based compensation plans

Proceeds from share issuances under share-based compensation plans at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX
$19.48M+715%
Silvaco Group, Inc. logo
Silvaco Group, Inc.SVCO
$3.99M+1,676%
Trex Company logo
Trex CompanyTREX
$286K-4.7%
Baxter International logo
Baxter InternationalBAX
$8M-20.0%
Crinetics Pharmaceuticals logo
Crinetics PharmaceuticalsCRNX
$10.15M-9.0%
American Superconductor logo
American SuperconductorAMSC
$149K-0.7%

Other financials

Income statement

See full
Revenue$470.0M-3.3%
Gross profit$209.7M-11.1%
Operating income-$51.0M-2,629%
Net income-$55.6M-209%
EPS (diluted)-$2.38-207%

Balance sheet

See full
Cash & equivalents$18.9M+0.1%
Total debt$840.7M-12.7%
Total equity$798.2M-52.6%
Total assets$2.1B-32.5%

Cash flow

See full
Operating cash flow$111.3M+218%
CapEx$8.2M+3.8%
Free cash flow$103.1M+281%

Valuation

See full
Market cap$648.22M+5.7%
Enterprise value$1.47B-2.2%
P/S0.4×0.0×

Profitability

See full
Gross margin45.7%-2.3pp
Operating margin-43.8%-51.3pp
Net margin-50.3%-56.8pp
FCF margin6%-3.1pp

Returns & leverage

See full
Return on equity-72.5%-79.9pp
Debt / equity1.1×+0.5×
Current ratio1.7×-0.3×

Where this comes from

Reported directly by Helen Of Troy in its filing.

Tagged under the XBRL concept hele:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsAndTaxBenefits.

The official record: Helen Of Troy’s 10-K, filed April 23, 2026, on SEC EDGAR. View the filing →

Ask your AI about Helen Of Troy's proceeds from share issuances under share-based compensation plans.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Helen Of Troy's proceeds from share issuances under share-based compensation plans?
Helen Of Troy (HELE) reported proceeds from share issuances under share-based compensation plans of $1K in Q4 2025.
What is the long-term trend for Helen Of Troy's proceeds from share issuances under share-based compensation plans?
Over 3 years (2022 to 2026), Helen Of Troy's proceeds from share issuances under share-based compensation plans has grown at a -21.1% compound annual growth rate (CAGR), from $5.96M to $2.93M.
What does proceeds from share issuances under share-based compensation plans mean?
This metric represents the cash inflows received by the company when employees or executives exercise stock options or purchase shares under equity-based compensation plans. It serves as a measure of the cash impact of employee equity programs and reflects the dilution or capital contribution from the workforce. Investors use this to understand the cash flow effects of incentive structures and the alignment between employee compensation and shareholder interests.